Effects of a Gonadotropin-Releasing Hormone agonist and Follicle Stimulating Hormone on the incidence of apoptosis in human luteinized granulosa cells
C. Sifer(Lyon 1 Université), Jean‐Louis Bénifla(Hôpital Bichat-Claude-Bernard), Raphaël Porcher(Hotel Dieu Hospital), Grazielle Blanc-Layrac(Lyon 1 Université), Patrick Madélénat(Schiller International University), Annie-France Bringuier(Inserm), Gérard Feldmann(Assistance Publique – Hôpitaux de Paris)
European Journal of Obstetrics & Gynecology and Reproductive Biology
August 7, 2003
Cited by 10
Related Papers
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
|The Lancet Respiratory Medicine|2021|297
Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)
|Intensive Care Medicine|2011|293
Effect of a diabetic environment in utero on predisposition to type 2 diabetes
|The Lancet|2003|286